Filter results
You can narrow down the results using the filters
Topic
- Advertising (214)
- COVID-19 (117)
- Medicines safety (93)
- COVID-19 vaccines (70)
- Prescription medicines (69)
- Regulatory compliance (69)
- Legislation (61)
- Medicines (56)
- Medical devices safety (35)
- Listed medicines (33)
- Medical devices (33)
- Non-prescription medicines (28)
- Therapeutic goods regulation (24)
- Manufacturing (22)
- Assessed listed medicines (21)
- Complementary medicines (21)
- Scheduling (national classification system) (21)
- Unapproved therapeutic goods (17)
- Labelling and packaging (15)
- Safety (13)
- Medicinal cannabis hub (10)
- Nicotine vaping products hub (10)
- Shortages (10)
- Over the counter medicine (9)
- Import and export (8)
- Sunscreens (8)
- Australian Register of Therapeutic Goods (ARTG) (7)
- In Vitro Diagnostic medical devices (IVDs) (7)
- Alert/Advisory (4)
- Compliance and enforcement hub (3)
- Advisory bodies and committees (2)
- Biologicals (2)
- Fees and payments (2)
- Weight loss products (2)
- Biological medicines (1)
- Blood and blood components (1)
- Blood safety (1)
- Clinical trials (1)
- Cosmetics (1)
- Other therapeutic goods (1)
- Prescription opioids hub (1)
- Travelling with health products (1)
- Unique Device Identification (UDI) Hub (1)
Search
901 result(s) found, displaying 151 to 175
- Media releasesNSW individual fined $2,664 for alleged unlawful advertising of nicotine vaping productsThe TGA has issued an infringement notice to a NSW-based individual for allegedly advertising nicotine vaping products for sale via their website.
- Media releasesPhenix Health Pty Ltd directed to cease alleged unlawful advertising of nicotine vaping productsThe TGA has issued a direction notice to Phenix Health Pty Ltd (Phenix) to cease promoting the use and supply of nicotine vaping products to Australian consumers.
- Media releasesTGA commences evaluation of Pfizer's COVID-19 vaccine (COMIRNATY) for children aged 6 months to less than 5 yearsTGA commences evaluation of Pfizer's COVID-19 vaccine (COMIRNATY) for children aged 6 months to less than 5 years
- COVID-19 vaccine safety reportsCOVID-19 vaccine safety report - 28-07-2022Information about the TGA's safety monitoring of COVID-19 vaccines.
- Compliance undertakingsEnforceable undertaking: Strapit Medical and Sports Supplies Pty LtdTGA accepts Enforceable Undertaking by Strapit Medical and Sports Supplies Pty Ltd in relation to breaches of the Therapeutic Goods Act.
- Media releasesRapid Antigen Test cancellations not due to the failure to detect the COVID-19 Omicron variantThe TGA is aware of several incorrect recent media reports asserting that some COVID-19 rapid antigen tests have been removed from the market by the TGA for failing to detect the Omicron COVID-19 variant.
- Media releasesStrapit Medical and Sports Supplies Pty Ltd undertakes to comply with advertising rules for therapeutic goodsTGA accepts Enforceable Undertaking by Strapit Medical and Sports Supplies Pty Ltd in relation to breaches of the Therapeutic Goods Act.
- Media releasesCourt proceedings initiated against Vapor Kings Pty Ltd and its director for alleged unlawful advertising of nicotine vaping productsThe TGA has commenced Federal Court proceedings against Vapor Kings Pty Ltd and its sole director for alleged unlawful advertising of nicotine vaping products.
- Media releasesInfluenza vaccine batch release for 2022 seasonTGA has released over 95 batches of influenza vaccine, consisting of over 16.8 million doses, for supply in Australia for the 2022 influenza season.
- NewsTGA approval to change blood donation rules relating to vCJD deferralThe TGA has approved the removal of the geographical deferral of blood and plasma donors from the UK, which was put in place to minimise the risk of variant Creutzfeldt-Jakob disease (vCJD), commonly known as 'mad cow disease'.
- Media releasesTGA provisionally approves the Biocelect Pty Ltd (Novavax) COVID-19 vaccine, NUVAXOVID, for use in individuals aged 12-17 yearsThe TGA has provisionally approved the Biocelect Pty Ltd (on behalf of Novavax Inc.) COVID-19 vaccine, NUVAXOVID, for use in individuals aged 12 years and older.
- Media releases13 Vape Pty Ltd directed to cease alleged unlawful advertising of nicotine vaping productsThe TGA has issued a direction notice to 13 Vape Pty Ltd and an executive officer to cease promoting the use and supply of nicotine vaping products to Australian consumers.
- NoticesTherapeutic Goods (Poisons Standard) (Benzylpenicillin - Seqirus) Exemption 2022This labelling exemption is granted under section 1.1(3) of Part 2 of the current Poisons Standard.
- Media releasesPerson fined $31,698 for alleged unlawful advertising of disposable nicotine vaping productsThe TGA has issued 12 infringement notices totalling $31,698 to a NSW based individual for alleged unlawful advertising of disposable nicotine vaping products on several websites.
- Media releasesTGA provisionally approves Moderna COVID-19 vaccine (SPIKEVAX) for use in children from 6 monthsThe TGA has provisionally approved a paediatric dose of the Moderna COVID-19 vaccine, SPIKEVAX, for use in individuals aged 6 months to less than 6 years (6 months to 5 years).
- COVID-19 vaccine safety reportsCOVID-19 vaccine safety report - 14-07-2022Information about the TGA's safety monitoring of COVID-19 vaccines.
- Safety updatesFirst-generation oral sedating antihistamines - do not use in childrenMedicines Safety Update - Information for health professionals
- Safety updatesProduct Information safety updates - July 2022Medicines Safety Update - Information for health professionals
- NewsSurrogate viruses for use in disinfectant efficacy tests to justify claims against MonkeypoxThe TGA is providing guidance on surrogate viruses that may be used to test disinfectants making claims of efficacy against Monkeypox.
- Media releasesTGA grants provisional determinations to Pfizer for COVID-19 vaccines to target Omicron variantOn 5 July 2022 the TGA granted two provisional determinations to Pfizer Australia Pty Ltd.
- NoticesDirection about advertisements: Precision Pharmaceuticals Pty LtdDirection Notice issued to cease advertisement of prescription and illegal products
- Media releasesPrecision Pharmaceuticals Pty Ltd fined and directed to cease alleged unlawful advertising of nicotine vaping productsPrecision Pharmaceuticals Pty Ltd fined and directed to cease alleged unlawful advertising of nicotine vaping products
- COVID-19 vaccine safety reportsCOVID-19 vaccine safety report - 30-06-2022Information about the TGA's safety monitoring of COVID-19 vaccines.
- Media releasesProvisional determination granted to Pfizer in relation to COVID 19 vaccine, COMIRNATY - for use in individuals 6 months up to 5 yearsOn 28 June 2022 the TGA granted a provisional determination to Pfizer Australia Pty Ltd in relation to its COVID-19 Vaccine, COMIRNATY.
- COVID-19 vaccine safety reportsCOVID-19 vaccine weekly safety report - 23-06-2022Information about the TGA's safety monitoring of COVID-19 vaccines.